CymaBay Therapeutics Inc - Company Profile

Powered by

All the sales intelligence you need on CymaBay Therapeutics Inc in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how CymaBay Therapeutics Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with CymaBay Therapeutics Inc.

Back to companies

CymaBay Therapeutics Inc: Premium Databases

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

CymaBay Therapeutics Clinical Trials

Determine CymaBay Therapeutics Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

A sample of CymaBay Therapeutics Clinical Trials data

Trial Title Trial Identifier Drug Name Therapy Area Indication Trial Phase Trial Status Sponsor
Showing 3 of 30+ results.
Deserunt mollit sunt Lorem GDCTWXYZ Lorem Lorem Lorem WXYZ Planned Pfizer Inc
RESPONSE: Response to Seladelpar in Subjects with Primary Biliary Cholangitis (PBC) and an Inadequate Control to or an Intolerance to Ursodeoxycholic Acid (UDCA) GDCT0404544 seladelpar lysine Gastrointestinal Primary Biliary Cholangitis (Primary Biliary Cirrhosis) Phase III Ongoing, not recruiting CymaBay Therapeutics Inc
Study Investigating the Safety, Tolerability, and PK, PD, of CB-0406 GDCT0393001 CB-0406 Immunology Inflammation Phase I Completed CymaBay Therapeutics Inc
A Study to Evaluate the Safety, and Tolerability, and Efficacy of Seladelpar in Patients with PSC GDCT0355474 seladelpar lysine Gastrointestinal Primary Sclerosing Cholangitis Phase II Completed CymaBay Therapeutics Inc
Clinical Trials

Feature

GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.

The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.

Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:

  • 250+ clinical trial registries
  • 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.

Benefit

The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).

Access:

  • Detailed trial information.
  • Drug information.
  • Patient information, including inclusion and exclusion criteria.
  • Trial results, as reported in the public domain.
  • Biomarkers used for patient stratification/selection & outcome measures.
  • Enrolment parameters.
  • Investigators involved in clinical trials.
  • Trials sites and locations.
  • Contact information.

Value

Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.

Geographic Analysis - see where trials are being run.

Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.

Find information on trials contacts, as well as Site and Investigator information.

Get information on trial successes and failures.

Get intelligence on CROs engaged in clinical trials.

Use as a business development tool for CROs.

Premium databases is part of our industry range of products

Gain a 360-degree view of CymaBay Therapeutics Inc and make more informed decisions for your business
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer